Pfizer Launches 2014 Integrated Annual Review
April 16 2015 - 8:30AM
Business Wire
Pfizer Inc. (NYSE:PFE) addresses some challenging questions
often posed by shareholders and the public in its latest integrated
annual review for 2014. In a series of video Q&As, Pfizer
colleagues respond to questions such as: “Why do people say
medicines are so expensive?” and “Why is it so difficult to find a
cure for cancer?”
The 2014 integrated report also highlights a number of
partnerships focused on collaborative research and development, how
Pfizer is tackling the rise in non-communicable diseases, and
access to medicines in low- and middle-income countries. Healthy
and active aging also figures prominently in the annual review,
reflecting the rapid shift in global demographics.
Ian C. Read, Pfizer chairman and chief executive officer, writes
in his annual letter to shareholders included in the annual review
that Pfizer “is on a multi-year journey, and during 2014 we
achieved a number of important milestones despite a slow-growth
global economy and the losses of exclusivity and co-promotion
rights to some of our major medicines. We are concentrating our
efforts on seeking to profitably grow our business and expanding
our sources of revenue, strengthening our core businesses, and
bringing forth new therapies that significantly improve peoples'
lives.”
Pfizer Inc.: Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products. Our global portfolio includes medicines and vaccines as
well as many of the world's best-known consumer health care
products. Everyday, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier
innovative biopharmaceutical companies, we collaborate with health
care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world.
For more than 150 years, Pfizer has worked to make a difference for
all who rely on us. To learn more, please visit us at
www.pfizer.com.
DISCLOSURE NOTICE: The information contained in this
release is as of April 16, 2015. Pfizer assumes no obligation to
update forward-looking statements contained in this release as the
result of new information or future events or developments.
This release contains forward-looking information that involves
substantial risks and uncertainties that could cause actual results
to differ materially from those expressed or implied by such
statements. A description of risks and uncertainties can be found
in Pfizer's Annual Report on Form 10-K for the fiscal year ended
December 31, 2014 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned "Risk Factors" and
"Forward-Looking Information That May Affect Future Results", as
well as in its subsequent reports on Form 8-K, all of which are
filed with the SEC and available at www.sec.gov and
www.pfizer.com.
Pfizer Inc.Media RelationsAndrew Topen, 212-733-1338orInvestor
RelationsRyan Crowe, 212-733-8160
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024